Relay Therapeutics, Inc. (RLAY) › Shareholders' EquityRelay Therapeutics, Inc. (RLAY) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$110.93M2019: -$180.44M2020: $763.29M2021: $897.81M2022: $950.22M2023: $752.00M2024: $777.79M2025: $567.06M$567.06M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$567.06M-27.1%2024$777.79M+3.4%2023$752.00M-20.9%2022$950.22M+5.8%2021$897.81M+17.6%2020$763.29M+523.0%2019-$180.44M-62.7%2018-$110.93M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share